AHLA Recently Launched a New Publication to Aid Professionals in the Pharmaceutical and Device Industry

Washington, D.C. -- AHLA recently released a new publication, Market Access, Pricing, and Reimbursement of Drugs and Devices: Legal Principles and Practice. Written and edited by lawyers at Covington & Burling LLP, this publication is designed to aid professionals who practice in the pharmaceutical and device industry.  

The landscape for market access is constantly evolving, and new federal policy initiatives will continue to present a dynamic environment for market access practitioners. Government regulations, rapid policy shifts, and increasing scrutiny make market access compliance a growing area of focus for life sciences companies. This new resource examines legal and business considerations relating to drug and device manufacturing and distribution, including market access, pricing, reimbursement, and promotion.  

"After years of addressing client questions relating to market access, pricing, and reimbursement of drugs and devices, we realized there was a clear gap in the legal literature to help health care professionals better understand and navigate these issues in a thoughtful, strategic, and compliant manner," said Rujul Desai, a partner at Covington." A core team of Covington lawyers came together to fully author and edit this new treatise to fill that gap and more broadly share Covington's deep expertise in these critical areas impacting the health care industry."

The authors of this resource are leading national and global experts in the life science field, providing sophisticated and accessible insight into this historically opaque area. Each chapter gives a foundational overview of core market access legal principles, covering discrete market access activities and advanced topics for readers who have been practicing for many years.  

This new publication is available for purchase. Interested parties can purchase this resource here.